Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.90

€2.90

9.350%
0.248
9.350%
?
 
12.08.22 / Frankfurt WKN: A1XAEB / Name: Quantum Genomics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Quantum Genomics S.A. Stock

A very strong showing by Quantum Genomics S.A. today, with an increase of €0.25 (9.350%) compared to yesterday's price.
The community is currently still undecided about Quantum Genomics S.A. with 1 Buy predictions and 0 Sell predictions.
With a target price of €5.00 there is a hugely positive potential of 72.414% for Quantum Genomics S.A. compared to the current price of €2.90.
So far the community has only identified positive things for Quantum Genomics S.A. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Quantum Genomics S.A. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Quantum Genomics S.A. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Quantum Genomics S.A. 9.350% 14.988% 53.683% -45.128% -29.577% - -
Poxel S.A. 2.620% 14.355% 48.734% -59.059% -52.119% -59.829% -59.434%
Cellectis Nom. 0.490% 7.993% 49.754% -66.002% -50.736% -66.957% -
Valneva SE -0.500% 3.109% 0.000% -13.403% -59.782% 233.893% 247.902%

News

Quantum Genomics announces the appointment of its new Scientific Advisory Board

Quantum Genomics announces the appointment of its new Scientific Advisory Board

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development